Literature DB >> 24903967

Presence of voltage-gated potassium channel complex antibody in a case of genetic prion disease.

Adham Jammoul1, Richard J Lederman1, Jinny Tavee2, Yuebing Li2.   

Abstract

Voltage-gated potassium channel (VGKC) complex antibody-mediated encephalitis is a recently recognised entity which has been reported to mimic the clinical presentation of Creutzfeldt-Jakob disease (CJD). Testing for the presence of this neuronal surface autoantibody in patients presenting with subacute encephalopathy is therefore crucial as it may both revoke the bleak diagnosis of prion disease and allow institution of potentially life-saving immunotherapy. Tempering this optimistic view is the rare instance when a positive VGKC complex antibody titre occurs in a definite case of prion disease. We present a pathologically and genetically confirmed case of CJD with elevated serum VGKC complex antibody titres. This case highlights the importance of interpreting the result of a positive VGKC complex antibody with caution and in the context of the overall clinical manifestation. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24903967      PMCID: PMC4054324          DOI: 10.1136/bcr-2013-201622

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  11 in total

Review 1.  NMDA receptor autoantibodies in sporadic Creutzfeldt-Jakob disease.

Authors:  Graham Mackay; Kate Ahmad; Jon Stone; Cathie Sudlow; David Summers; Richard Knight; Robert Will; Sarosh R Irani; Angela Vincent; Paul Maddison
Journal:  J Neurol       Date:  2012-04-18       Impact factor: 4.849

2.  Voltage-gated potassium channel complex antibodies in Creutzfeldt-Jakob disease.

Authors:  Koji Fujita; Tatsuhiko Yuasa; Osamu Watanabe; Yukitoshi Takahashi; Shuji Hashiguchi; Katsuhito Adachi; Yuishin Izumi; Ryuji Kaji
Journal:  J Neurol       Date:  2012-05-26       Impact factor: 4.849

3.  Characterization of the prion protein 3F4 epitope and its use as a molecular tag.

Authors:  Christoffer Lund; Christel Moraeus Olsen; Heidi Tveit; Michael A Tranulis
Journal:  J Neurosci Methods       Date:  2007-06-13       Impact factor: 2.390

4.  Antibodies to N-methyl-D-aspartate glutamate receptors in Creutzfeldt-Jakob disease patients.

Authors:  Koji Fujita; Tatsuhiko Yuasa; Yukitoshi Takahashi; Keiko Tanaka; Wataru Sako; Hidetaka Koizumi; Yasushi Iwasaki; Mari Yoshida; Yuishin Izumi; Ryuji Kaji
Journal:  J Neuroimmunol       Date:  2012-07-17       Impact factor: 3.478

5.  Genetic prion disease: the EUROCJD experience.

Authors:  Gábor G Kovács; Maria Puopolo; Anna Ladogana; Maurizio Pocchiari; Herbert Budka; Cornelia van Duijn; Steven J Collins; Alison Boyd; Antonio Giulivi; Mike Coulthart; Nicole Delasnerie-Laupretre; Jean Philippe Brandel; Inga Zerr; Hans A Kretzschmar; Jesus de Pedro-Cuesta; Miguel Calero-Lara; Markus Glatzel; Adriano Aguzzi; Matthew Bishop; Richard Knight; Girma Belay; Robert Will; Eva Mitrova
Journal:  Hum Genet       Date:  2005-11-15       Impact factor: 4.132

6.  Autoantibodies against axonal neurofilaments in patients with Kuru and Creutzfeldt-Jakob disease.

Authors:  J Sotelo; C J Gibbs; D C Gajdusek
Journal:  Science       Date:  1980-10-10       Impact factor: 47.728

7.  Voltage-gated potassium channel autoimmunity mimicking creutzfeldt-jakob disease.

Authors:  Michael D Geschwind; K Meng Tan; Vanda A Lennon; Ramon F Barajas; Aissa Haman; Christopher J Klein; S Andrew Josephson; Sean J Pittock
Journal:  Arch Neurol       Date:  2008-10

8.  Autoantibodies in sporadic Creutzfeldt-Jakob disease.

Authors:  Heather Angus-Leppan; Peter Rudge; Simon Mead; John Collinge; Angela Vincent
Journal:  JAMA Neurol       Date:  2013-07       Impact factor: 18.302

9.  Determination of neuronal antibodies in suspected and definite Creutzfeldt-Jakob disease.

Authors:  Oriol Grau-Rivera; Raquel Sánchez-Valle; Albert Saiz; José Luis Molinuevo; Reyes Bernabé; Elvira Munteis; Francesc Pujadas; Antoni Salvador; Júlia Saura; Antonio Ugarte; Maarten Titulaer; Josep Dalmau; Francesc Graus
Journal:  JAMA Neurol       Date:  2014-01       Impact factor: 18.302

10.  Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia.

Authors:  Sarosh R Irani; Sian Alexander; Patrick Waters; Kleopas A Kleopa; Philippa Pettingill; Luigi Zuliani; Elior Peles; Camilla Buckley; Bethan Lang; Angela Vincent
Journal:  Brain       Date:  2010-07-27       Impact factor: 13.501

View more
  2 in total

1.  LGI1 antibody encephalopathy overlapping with sporadic Creutzfeldt-Jakob disease.

Authors:  Boaz Kim; Patrick Yoo; Tom Sutherland; Alison Boyd; Christiane Stehmann; Catriona McLean; Steven Collins
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2016-06-16

Review 2.  Current Nosology of Neural Autoantibody-Associated Dementia.

Authors:  Niels Hansen
Journal:  Front Aging Neurosci       Date:  2021-07-28       Impact factor: 5.750

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.